Cargando…

Advances in the management of pancreatic ductal adenocarcinoma

Detalles Bibliográficos
Autores principales:	O’Kane, Grainne M., Ladak, Farah, Gallinger, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Joule Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203253/ https://www.ncbi.nlm.nih.gov/pubmed/34099468 http://dx.doi.org/10.1503/cmaj.201450

Ejemplares similares

Avancées dans la prise en charge de l’adénocarcinome canalaire pancréatique
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023)

Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
por: Franck, Caspar, et al.
Publicado: (2020)

The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer
por: Duan, Kai, et al.
Publicado: (2021)

CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging
por: Zhang, Yucheng, et al.
Publicado: (2020)

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
por: Fan, Jia-qiao, et al.
Publicado: (2020)

Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
por: Barcellini, Amelia, et al.
Publicado: (2020)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions
por: Yamada, Reiko, et al.
Publicado: (2023)

Determinants of gemcitabine response in pancreatic cancer: are we there?
por: Fitzpatrick, Orla M., et al.
Publicado: (2023)

Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Zhang, Yucheng, et al.
Publicado: (2020)

Recent advances in precision medicine for pancreatic ductal adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
por: Kane, Sujata, et al.
Publicado: (2020)

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
por: Golesworthy, Bryn, et al.
Publicado: (2022)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
por: Feigin, Michael E., et al.
Publicado: (2017)

Apoptotic pathways in pancreatic ductal adenocarcinoma
por: Hamacher, Rainer, et al.
Publicado: (2008)

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma
por: Topham, James T., et al.
Publicado: (2022)

Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options
por: Diwakarla, Chandra, et al.
Publicado: (2017)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
por: Karimnia, Vida, et al.
Publicado: (2021)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Wei, Kongyuan, et al.
Publicado: (2021)

Genetics and biology of pancreatic ductal adenocarcinoma
por: Ying, Haoqiang, et al.
Publicado: (2016)

Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
por: Li, Junjie, et al.
Publicado: (2016)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
por: Melzer, Michael Karl, et al.
Publicado: (2020)

Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
por: Sulciner, Megan L., et al.
Publicado: (2022)

Surgical management of pancreatic ductal adenocarcinoma: a narrative review
por: Sarfaty, Elad, et al.
Publicado: (2023)

CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis
por: Eilaghi, Armin, et al.
Publicado: (2017)

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma
por: Aung, Kyaw L., et al.
Publicado: (2022)

Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future
por: Goel, Gaurav, et al.
Publicado: (2015)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011)

Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
por: Lintern, Nicole, et al.
Publicado: (2023)

The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
por: Low, Ronnie Ren Jie, et al.
Publicado: (2021)

Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
por: Kruger, Deirdré, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_taaefeb75udvogtj1v9ahvhnbq